Incannex Healthcare (IXHL) Construction in Progress (2023)
Incannex Healthcare (IXHL) posted quarterly Construction in Progress of $160000.0 for Q2 2023.
Incannex Healthcare (IXHL) Construction in Progress (2023) Analysis & Trends
Incannex Healthcare (IXHL) has reported Construction in Progress for 1 consecutive years, with $160000.0 the latest figure, recorded in Q2 2023.
- Quarterly Construction in Progress changed N/A year-over-year to $160000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $160000.0 (changed N/A YoY) and the FY2023 annual result came in at $160000.0, changed N/A from the prior year.
- Construction in Progress was little changed at $160000.0 in Q2 2023 per IXHL's latest filing.
- Over the last five years, Construction in Progress for IXHL reached as high as $160000.0 in Q2 2023 and fell as low as $160000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 160,000.00 |